Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

676 articles

Research Review

Showing 1–1 of 1 articles · Keyword: Solid lipid nanoparticle Clear keyword

Advanced pharmaceutical bulletin2026ResearchDrug Delivery

1. Bifunctional EGFR/CD44-Targeted Diabody-Decorated Doxorubicin-Loaded Solid Lipid Nanoparticles for Targeted Therapy in Triple-Negative Breast Cancer

Arastehfar M, Soleimani Badie M, Derakhshandeh K

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks targeted therapies, making its treatment highly challenging. This study aimed to design a novel dual-targeted drug delivery system to improve therapeutic efficacy and reduce the side effects of conventional chemotherapy. Solid…

Read the article

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.